The University of Chicago has been the site of extraordinary breakthroughs. Scientists are proving that transforming breakthroughs in prevention will originate from our newfound understanding of the human genome. Using systems-level science to decipher the interplay among vast networks of genes, the environment, and other factors will enable us to map the causes of cancer, predict cancer risks for individuals, and design personalized treatment approaches.
From landmark prostate cancer treatment in 1939, to the identification of the first chromosomal abnormality in leukemia in 1972, to the 1988 discovery of the molecular mechanism by which tamoxifen blocks the effects of estrogen, and the 2008 development of a new MRI procedure that can detect early breast cancer, UChicago has been At the Forefront of Discovery™.
See our Timeline of Major Discoveries.